BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15828745)

  • 1. Intranasal kennel cough vaccine protecting dogs from experimental Bordetella bronchiseptica challenge within 72 hours.
    Gore T; Headley M; Laris R; Bergman JG; Sutton D; Horspool LJ; Jacobs AA
    Vet Rec; 2005 Apr; 156(15):482-3. PubMed ID: 15828745
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine.
    Shade FJ; Goodnow RA
    Am J Vet Res; 1979 Sep; 40(9):1241-3. PubMed ID: 525927
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the mucosal immune response in dogs vaccinated with either an intranasal avirulent live culture or a subcutaneous antigen extract vaccine of Bordetella bronchiseptica.
    Davis R; Jayappa H; Abdelmagid OY; Armstrong R; Sweeney D; Lehr C
    Vet Ther; 2007; 8(1):32-40. PubMed ID: 17447223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Bordetella bronchiseptica in infectious tracheobronchitis in dogs.
    Keil DJ; Fenwick B
    J Am Vet Med Assoc; 1998 Jan; 212(2):200-7. PubMed ID: 9448823
    [No Abstract]   [Full Text] [Related]  

  • 5. Canine infectious tracheobronchitis.
    Compend Contin Educ Vet; 2007 Jul; 29(7):418-9. PubMed ID: 17727049
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of vaccination on experimental infection with Bordetella bronchiseptica in dogs.
    Ellis JA; Haines DM; West KH; Burr JH; Dayton A; Townsend HG; Kanara EW; Konoby C; Crichlow A; Martin K; Headrick G
    J Am Vet Med Assoc; 2001 Feb; 218(3):367-75. PubMed ID: 11201562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal vaccination of dogs with liver avirulent Bordetella bronchiseptica: correlation of serum agglutination titer and the formation of secretory IgA with protection against experimentally induced infectious tracheobronchitis.
    Bey RF; Shade FJ; Goodnow RA; Johnson RC
    Am J Vet Res; 1981 Jul; 42(7):1130-2. PubMed ID: 7271029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How well do vaccines for Bordetella bronchiseptica work in dogs? A critical review of the literature 1977-2014.
    Ellis JA
    Vet J; 2015 Apr; 204(1):5-16. PubMed ID: 25747699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy of an injectable vaccine and an intranasal vaccine in stimulating Bordetella bronchiseptica-reactive antibody responses in seropositive dogs.
    Ellis JA; Krakowka GS; Dayton AD; Konoby C
    J Am Vet Med Assoc; 2002 Jan; 220(1):43-8. PubMed ID: 12680446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of intranasal and oral vaccines against Bordetella bronchiseptica in dogs.
    Ellis JA; Gow SP; Waldner CL; Shields S; Wappel S; Bowers A; Lacoste S; Xu Z; Ball E
    Vet J; 2016 Jun; 212():71-7. PubMed ID: 27256028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough).
    Kontor EJ; Wegrzyn RJ; Goodnow RA
    Am J Vet Res; 1981 Oct; 42(10):1694-8. PubMed ID: 6275747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of a tracheobronchitis epizootic associated with Bordetella bronchiseptica in a closed dog colony.
    Shelton ME; Draper DD; Farrington DO
    Vet Med Small Anim Clin; 1977 Feb; 72(2):189-93. PubMed ID: 584586
    [No Abstract]   [Full Text] [Related]  

  • 13. Compatibility of a bivalent modified-live vaccine against Bordetella bronchiseptica and CPiV, and a trivalent modified-live vaccine against CPV, CDV and CAV-2.
    Jacobs AA; Bergman JG; Theelen RP; Jaspers R; Helps JM; Horspool LJ; Paul G
    Vet Rec; 2007 Jan; 160(2):41-5. PubMed ID: 17220520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of the nasal shedding kinetics of field and vaccine strains of Bordetella bronchiseptica.
    Iemura R; Tsukatani R; Micallef MJ; Taneno A
    Vet Rec; 2009 Dec; 165(25):747-51. PubMed ID: 20023279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A doggy tale: Risk of zoonotic infection with Bordetella bronchiseptica for cystic fibrosis (CF) patients from live licenced bacterial veterinary vaccines for cats and dogs.
    Moore JE; Rendall JC; Millar BC
    J Clin Pharm Ther; 2022 Feb; 47(2):139-145. PubMed ID: 34328230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of 1-year duration of immunity for attenuated Bordetella bronchiseptica vaccines in dogs.
    Lehar C; Jayappa H; Erskine J; Brown A; Sweeney D; Wassmoen T
    Vet Ther; 2008; 9(4):257-62. PubMed ID: 19177330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kennel cough: Vaccination against Bordetella bronchiseptica infection.
    McCandlish IA; Thompson H; Wright NG
    Vet Rec; 1976 Feb; 98(8):156-7. PubMed ID: 1266000
    [No Abstract]   [Full Text] [Related]  

  • 18. Intranasal vaccine trial for canine infectious tracheobronchitis (kennel cough).
    Glickman LT; Appel MJ
    Lab Anim Sci; 1981 Aug; 31(4):397-9. PubMed ID: 6273648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vaccinated dogs.
    Gisel JJ; Brumble LM; Johnson MM
    Transpl Infect Dis; 2010 Feb; 12(1):73-6. PubMed ID: 19874567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerned with welfare of dogs in research.
    Field P
    J Am Vet Med Assoc; 2001 Apr; 218(8):1259-60. PubMed ID: 11330603
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.